Glaxo agrees to pay $3 billion to settle marketing probes
Today GlaxoSmithKline (GSK), the U.K.s biggest drug company, announced that it has agreed to pay the U.S. government $3 billion to settle several criminal and civil probes related to its sales and marketing practices.
By Ashley Post|November 03, 2011
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.